60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) started the day on Wednesday, with a price decrease of -9.57% at $0.48, before settling in for the price of $0.53 at the close. Taking a more long-term approach, SXTP posted a 52-week range of $0.45-$6.00.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 12.29%. Meanwhile, its Annual Earning per share during the time was 12.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 84.04%. This publicly-traded company’s shares outstanding now amounts to $4.10 million, simultaneously with a float of $4.10 million. The organization now has a market capitalization sitting at $2.02 million.
60 Degrees Pharmaceuticals Inc (SXTP) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. 60 Degrees Pharmaceuticals Inc’s current insider ownership accounts for 3.19%, in contrast to 1.01% institutional ownership. According to the most recent insider trade that took place on Dec 15 ’25, this organization’s President and CEO bought 9,670 shares at the rate of 0.80, making the entire transaction reach 7,759 in total value, affecting insider ownership by 59,618. Preceding that transaction, on Dec 10 ’25, Company’s President and CEO bought 9,350 for 0.95, making the whole transaction’s value amount to 8,886. This particular insider is now the holder of 46,335 in total.
60 Degrees Pharmaceuticals Inc (SXTP) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
60 Degrees Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 84.04% and is forecasted to reach -1.73 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 70.24% through the next 5 years, which can be compared against the 12.29% growth it accomplished over the previous five years trading on the market.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Let’s observe the current performance indicators for 60 Degrees Pharmaceuticals Inc (SXTP). It’s Quick Ratio in the last reported quarter now stands at 2.63. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.49.
In the same vein, SXTP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -7.32, a figure that is expected to reach -0.57 in the next quarter, and analysts are predicting that it will be -1.73 at the market close of one year from today.
